An idiotic governmental policy that will take your breath away literally

By ACSH Staff — May 12, 2015
When it comes to government policies regarding health policy, we've seen pretty much every type: Meaningless, but mostly harmless, anti-science, money driven, and ill-conceived and harmful.

When it comes to government policies regarding health policy, we've seen pretty much every type: Meaningless, but mostly harmless, anti-science, money driven, and ill-conceived and harmful.

Louisville Professor Brad Rodu s call for more access for smokers to smoke-free nicotine

By ACSH Staff — May 12, 2015
Dr. Brad Rodu is a Professor of Medicine at the University of Louisville. He has been an ACSH advisor for many years, and has written or co-written many of our publications on tobacco harm reduction. He was also a member of the ACSH Panel at the American Academy for the Advancement of Science

Dr. Brad Rodu is a Professor of Medicine at the University of Louisville. He has been an ACSH advisor for many years, and has written or co-written many of our publications on tobacco harm reduction.
He was also a member of the ACSH Panel at the American Academy for the Advancement of Science

BPA to join California s Proposition 65 List. Who Cares?

By ACSH Staff — May 11, 2015
It s Monday morning. No one is in a particularly good mood. This didn't help. We have been discussing BPA a component of polycarbonate and polyether plastics forever. This should be #1000 on your list of things to worry about (#999 is being hit by a giraffe that fell off a skyscraper.)

It s Monday morning. No one is in a particularly good mood. This didn't help.
We have been discussing BPA a component of polycarbonate and polyether plastics forever. This should be #1000 on your list of things to worry about (#999 is being hit by a giraffe that fell off a skyscraper.)

Dr. Gawande explores the rationale for our irrational healthcare spending

By ACSH Staff — May 11, 2015
Why do healthcare expenditures in the U.S. tower over those of other wealthy countries? And why are the health benefits we receive not commensurate with all those billions spent? Dr. Atul Gawande has some thoughts on this in The New Yorker.

Why do healthcare expenditures in the U.S. tower over those of other wealthy countries? And why are the health benefits we receive not commensurate with all those billions spent? Dr. Atul Gawande has some thoughts on this in The New Yorker.

The SciBabe strikes hard at the Natural Food Movement

By ACSH Staff — May 11, 2015
Maybe the name Yvette d'Entremont doesn t a ring a bell to you, or maybe you know her by her internet persona: The SciBabe. Whatever your familiarity level is with her you need to dial it way up. Start following and listening to her because she is bringing the heat. Last

Maybe the name Yvette d'Entremont doesn t a ring a bell to you, or maybe you know her by her internet persona: The SciBabe. Whatever your familiarity level is with her you need to dial it way up. Start following and listening to her because she is bringing the heat. Last

Many Europeans want to ban animal research: let s hope saner heads prevail

By ACSH Staff — May 11, 2015
To many animal lovers, it may seem like a no-brainer research on animals should be banned. And this is the stance of over one million Europeans who signed a petition that the European Parliament is currently considering.

To many animal lovers, it may seem like a no-brainer research on animals should be banned. And this is the stance of over one million Europeans who signed a petition that the European Parliament is currently considering.

Personalized medicine continues to explode, especially against cancer

By ACSH Staff — May 08, 2015
We have seen some remarkable medical breakthroughs in the past two decades. In terms of sheer impact, it could be argued that transforming HIV infection from a certain death sentence into a manageable chronic disease, and a cure for hepatitis C, which is four times more prevalent than HIV worldwide, are at or near the top of this list.

We have seen some remarkable medical breakthroughs in the past two decades. In terms of sheer impact, it could be argued that transforming HIV infection from a certain death sentence into a manageable chronic disease, and a cure for hepatitis C, which is four times more prevalent than HIV worldwide, are at or near the top of this list.

CDC: Too few getting recommended cancer tests." We say, let s discuss

By ACSH Staff — May 08, 2015
The CDC has released its survey data on how many Americans are getting the recommended cancer screening test for cervical, breast and colorectal cancer. They believe too few are following their advice. We think the issue is more nuanced.

The CDC has released its survey data on how many Americans are getting the recommended cancer screening test for cervical, breast and colorectal cancer. They believe too few are following their advice. We think the issue is more nuanced.